A 38-year-old man from rural India presents with jaundice, dark urine, and abdominal pain for 2 weeks. Serum bilirubin is 8.2 mg/dL (direct 6.1 mg/dL), ALT 1200 IU/L, AST 980 IU/L, and ALP 180 IU/L. Serological testing shows anti-HAV IgM positive, anti-HBc negative, anti-HCV negative. Which of the following is NOT true regarding his condition?

Explanation

## Hepatitis A: Clinical Features and Natural History ### Epidemiology and Transmission **Key Point:** Hepatitis A is transmitted exclusively via the fecal-oral route, typically through contaminated food or water. There is no chronic carrier state — all infected individuals either recover completely or progress to fulminant failure. ### Acute Infection Outcomes | Outcome | Frequency in Adults | Notes | |---------|---------------------|-------| | Complete recovery | 99.5–99.9% | Develops lifelong immunity | | Fulminant hepatic failure | 0.1–0.4% | Higher in elderly and those with pre-existing liver disease | | Chronic infection | 0% | Does NOT occur in HAV | | Relapsing hepatitis | Rare (~3–5%) | Biphasic illness, not true chronicity | **High-Yield:** HAV never causes chronic hepatitis or a chronic carrier state. This is a fundamental distinction from HBV and HCV. ### Management Approach 1. Supportive care (fluid balance, nutritional support) 2. Serial monitoring of PT/INR, bilirubin, and encephalopathy signs 3. Avoid hepatotoxic drugs 4. No antiviral therapy (not effective; self-limited disease) 5. Admission criteria: INR >1.5, encephalopathy, or severe coagulopathy **Clinical Pearl:** Even in fulminant cases, if the patient survives the acute phase, complete hepatic recovery is expected with no residual fibrosis or cirrhosis. ### Why the Distractor is Wrong The statement "Chronic carrier state develops in 5–10% of acutely infected adults" is the **incorrect** option. This describes HBV (2–10% chronicity in adults, higher in neonates/infants), not HAV. HAV has 0% chronicity in immunocompetent hosts.